Chimeric antigen receptor T-cell therapy for melanoma

Author:

Razavi Azadehsadat123,Keshavarz-Fathi Mahsa24ORCID,Pawelek John5,Rezaei Nima367

Affiliation:

1. Department of Animal Biology, Faculty of Biology Sciences, University of Kharazmi, Tehran, Iran

2. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran

3. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

4. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

5. Department of Dermatology and the Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA

6. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

7. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Stockholm, Sweden

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Chimeric Antigen Receptor Therapy in Acute Myeloid Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors;Hematology/Oncology Clinics of North America;2023-12

3. Immunotherapy for mucosal melanoma;Oncology and Translational Medicine;2023-12

4. TIL-Derived CAR T Cells Improve Immune Cell Infiltration and Survival in the Treatment of CD19-Humanized Mouse Colorectal Cancer;Cancers;2023-11-24

5. Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma;Frontiers in Immunology;2023-10-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3